Pfizer's Trading Volume Drops 24.45% to $734 Million, Ranked 97th in Daily Volume

On June 18, 2025, Pfizer's trading volume reached $734 million, marking a 24.45% decrease from the previous day. This placed Pfizer at the 97th position in terms of trading volume for the day. Pfizer's stock price fell by 0.46%, marking the fourth consecutive day of decline, with a total decrease of 3.82% over the past four days.

Option traders have shown a moderate bearish sentiment towards Pfizer, with the stock price experiencing a slight decline. The options volume is roughly in line with the average, with 46,000 contracts traded and calls leading puts, resulting in a put/call ratio of 0.88, compared to the typical level near 0.7. The implied volatility (IV30) has increased by 0.4 points to 22.59, which is in the bottom quartile of the past year, suggesting an expected daily move of $0.34. The put-call skew has steepened, indicating an increased demand for downside protection.

Lawmakers are pressing for regulatory changes that could impact the pharmaceutical industry, including Pfizer. This regulatory pressure, combined with the moderate bearish sentiment among option traders, suggests that some investors are positioning for further downside in Pfizer's stock price. The current technical indicators also point to a bearish sentiment, with the Fear & Greed Index showing a reading of 39, indicating fear in the market.

Pfizer's stock has been maintaining a downtrend in 2025, facing bearish pressure. Moving averages and price performance indicate a prolonged correction, which could continue to weigh on the stock price. Despite the challenges, Pfizer's juicy dividend pays investors handsomely, providing a source of income while waiting for the company to deliver on its potential.